BlackRock Health Sciences Opps R BHSRX

Medalist Rating as of | See BlackRock Investment Hub
  • NAV / 1-Day Return 68.34  /  +0.21 %
  • Total Assets 8.3 Bil
  • Adj. Expense Ratio
    1.460%
  • Expense Ratio 1.460%
  • Distribution Fee Level Average
  • Share Class Type Retirement, Medium
  • Category Health
  • Investment Style Large Blend
  • Min. Initial Investment 100
  • Status Open
  • TTM Yield 0.00
  • Turnover 27%

USD | NAV as of Oct 05, 2024 | 1-Day Return as of Oct 05, 2024, 1:01 AM GMT+0

Morningstar’s Analysis BHSRX

Will BHSRX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

BlackRock Health Sciences Opps R’s Process Pillar rating is Average, but a strong management team still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BHSRX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 46.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

UnitedHealth Group Inc

9.27 810.5 Mil
Healthcare

Eli Lilly and Co

8.20 716.6 Mil
Healthcare

Boston Scientific Corp

5.73 500.6 Mil
Healthcare

Amgen Inc

3.94 344.2 Mil
Healthcare

Thermo Fisher Scientific Inc

3.64 318.2 Mil
Healthcare

Intuitive Surgical Inc

3.42 299.2 Mil
Healthcare

Danaher Corp

3.35 292.9 Mil
Healthcare

AbbVie Inc

3.35 292.8 Mil
Healthcare

Elevance Health Inc

2.99 261.2 Mil
Healthcare

Stryker Corp

2.77 242.3 Mil
Healthcare

Sponsor Center